New antibiotic '100-times more effective at treating TB'
The KKL-35 antibiotic could treat anthrax and tuberculosis by disrupting trans-translation.
A team of scientists led by Penn State University's Kenneth Keiler have discovered a new antibiotic that could be 100-times more effective than current therapies at treating tuberculosis (TB).
Researchers analysed and tested thousands of molecules in order to identify those which effectively disturbed the process of trans-translation in bacteria - one called KKL-35 has shown most promise.
This biological procedure helps ensure that protein synthesis functions properly in these pathogens, so its disruption can prevent the multiplication and spread of bacteria, curbing infection.
Experimenters tested the efficacy of molecules at disturbing trans-translation in Shigella, Bacillus anthracis and Mycobacterium tuberculosis strains. Successful inhibition by KKL-35 suggests it could have clinical applications.
"In our laboratory experiments, we found no mutant strains that were resistant to KKL-35," Keller said. "Resistant mutants probably would evolve eventually, but at least it looks like it will be very difficult."
The antibiotic was up to 100-times more effective at restricting growth of bacteria, but the outcome was only witnessed in a petri dish - a clinical trial in human volunteers may be the next step for determining benefits of the drug.
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance